Search

Author/Creator Bekaii-Saab, Tanios

2. A modified regimen of biweekly gemcitabine and nab-paclitaxel in patients with metastatic pancreatic cancer is both tolerable and effective: a retrospective analysis. (February 2017)

Authors:
Ahn, Daniel H.; Krishna, Kavya; Blazer, Marlo; Reardon, Joshua; Wei, Lai; Wu, Christina; Ciombor, Kristen K.; Noonan, Anne M.; Mikhail, Sameh; Bekaii-Saab, Tanios
Journal:
Therapeutic advances in medical oncology
Issue:
Volume 9:Number 2(2017:Mar.)
Page Start:
75
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Anti-IL-6 and PD-L1 antibody combination therapy reduces tumor progression in murine models of pancreatic cancer. (4th November 2015)

Authors:
Mace, Thomas; Shakya, Reena; Pitarresi, Jason; Loftus, Shannon; Swanson, Benjamin; Young, Gregory; Zhong, Xioling; Zimmers, Teresa; Ostrowski, Michael; Ludwig, Thomas; Bloomston, Mark; Bekaii-Saab, Tanios; Lesinski, Gregory
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 3(2015)Supplement 2
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Anti-IL-6 and PD-L1 antibody combination therapy reduces tumor progression in murine models of pancreatic cancer. Issue 2 (December 2015)

Authors:
Mace, Thomas; Shakya, Reena; Pitarresi, Jason; Loftus, Shannon; Swanson, Benjamin; Young, Gregory; Zhong, Xioling; Zimmers, Teresa; Ostrowski, Michael; Ludwig, Thomas; Bloomston, Mark; Bekaii-Saab, Tanios; Lesinski, Gregory
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 3:Issue 2(2015)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. CanStem111P trial: a Phase III study of napabucasin plus nab-paclitaxel with gemcitabine. (13th February 2019)

Authors:
Sonbol, Mohamad Bassam; Ahn, Daniel H; Goldstein, David; Okusaka, Takuji; Tabernero, Josep; Macarulla, Teresa; Reni, Michele; Li, Chung-Pin; O'Neil, Bert; Van Cutsem, Eric; Bekaii-Saab, Tanios
Journal:
Future oncology
Issue:
Volume 15:Number 12(2019)
Page Start:
1295
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Cetuximab and Irinotecan With or Without Bevacizumab in Refractory Metastatic Colorectal Cancer: BOND-3, an ACCRU Network Randomized Clinical Trial. (26th February 2022)

Authors:
Lipsyc-Sharf, Marla; Ou, Fang-Shu; Yurgelun, Matthew B; Rubinson, Douglas A; Schrag, Deborah; Dakhil, Shaker R; Stella, Philip J; Weckstein, Douglas J; Wender, Donald B; Faggen, Meredith; Zemla, Tyler J; Heying, Erica N; Schuetz, Samantha R; Noble, Stephanie; Meyerhardt, Jeffrey A; Bekaii-Saab, T...
Journal:
Oncologist
Issue:
Volume 27:Number 4(2022)
Page Start:
292
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗